CVT-6883 Uses, Dosage, Side Effects and more
CVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation and fibrosis.
| Trade Name | CVT-6883 |
| Generic | CVT-6883 |
| Type | |
| Formula | C21H21F3N6O2 |
| Weight | Average: 446.434 Monoisotopic: 446.167808429 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in asthma.
